Pateclizumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Pateclizumab Usage And Synthesis

Uses

Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1].

References

[1] Brinda Emu, et al. Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial. DOI:10.1186/ar3554

Pateclizumab(1202526-59-7)Related Product Information

• Vesencumab
• Benufutamab
• Bectumomab
• Research Grade Vandortuzumab (DHJ76001)
• Mavezelimab
• Ivonescimab
• Bleselumab
• Vepalimomab
• Atoltivimab
• Lirentelimab